Matt Cummings
Chief Executive Officer Precisio Biotix Therapeutics
Seminars
Wednesday 25th March 2026
Translating Novel Modalities from Concept to Clinic to Strengthen Phage’s Therapeutic Future
4:30 pm
- Addressing CMC, stability, and delivery challenges unique to synthetic or proteinbased antimicrobials
- Aligning development pathways with evolving regulatory expectations for nontraditional therapeutics
- Ensuring robust preclinical models and manufacturing scalability to accelerate realworld clinical adoption
